National Research Corporation (NRC)
USD 17.18
(-2.83%)
USD 17.18
(-2.83%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 45.98 Million USD | -11.35% |
| 2022 | 51.83 Million USD | -8.46% |
| 2021 | 56.66 Million USD | 12.76% |
| 2020 | 50.78 Million USD | 4.37% |
| 2019 | 48.14 Million USD | 15.51% |
| 2018 | 41.68 Million USD | 7.02% |
| 2017 | 38.95 Million USD | 8.89% |
| 2016 | 35.77 Million USD | 12.88% |
| 2015 | 31.68 Million USD | -1.59% |
| 2014 | 32.2 Million USD | 12.52% |
| 2013 | 28.61 Million USD | 4.26% |
| 2012 | 27.44 Million USD | 15.26% |
| 2011 | 23.85 Million USD | 28.25% |
| 2010 | 18.51 Million USD | 5.92% |
| 2009 | 17.35 Million USD | 19.12% |
| 2008 | 14.71 Million USD | 6.24% |
| 2007 | 13.94 Million USD | 13.32% |
| 2006 | 12.16 Million USD | 20.0% |
| 2005 | 10.17 Million USD | 8.09% |
| 2004 | 9.41 Million USD | 6.85% |
| 2003 | 8.9 Million USD | 8.1% |
| 2002 | 8.09 Million USD | 75.48% |
| 2001 | 4.62 Million USD | 0.37% |
| 2000 | 4.59 Million USD | 40.38% |
| 1999 | 2.9 Million USD | -42.11% |
| 1998 | 3.5 Million USD | -10.94% |
| 1997 | 5.1 Million USD | 77.78% |
| 1996 | 3.8 Million USD | 17.72% |
| 1995 | 3.05 Million USD | 75.34% |
| 1994 | 1.74 Million USD | 210.87% |
| 1993 | 561 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 10.24 Million USD | -22.47% |
| 2024 Q2 | 10.37 Million USD | 1.68% |
| 2024 Q3 | 9.54 Million USD | -8.0% |
| 2023 Q3 | 11.75 Million USD | 5.35% |
| 2023 Q4 | 13.13 Million USD | 11.77% |
| 2023 FY | - USD | -11.35% |
| 2023 Q1 | 10.64 Million USD | -22.3% |
| 2023 Q2 | 11.15 Million USD | 4.8% |
| 2022 Q4 | 13.7 Million USD | 10.22% |
| 2022 Q2 | 12.67 Million USD | -3.02% |
| 2022 FY | - USD | -8.46% |
| 2022 Q1 | 13.06 Million USD | -8.29% |
| 2022 Q3 | 12.43 Million USD | -1.9% |
| 2021 Q1 | 14.02 Million USD | 6.25% |
| 2021 FY | - USD | 12.76% |
| 2021 Q2 | 13.95 Million USD | -0.55% |
| 2021 Q4 | 14.24 Million USD | -1.31% |
| 2021 Q3 | 14.43 Million USD | 3.48% |
| 2020 Q1 | 13.2 Million USD | 0.83% |
| 2020 Q2 | 10.41 Million USD | -21.15% |
| 2020 Q3 | 13.43 Million USD | 28.98% |
| 2020 Q4 | 13.2 Million USD | -1.7% |
| 2020 FY | - USD | 4.37% |
| 2019 Q1 | 11.84 Million USD | 2.74% |
| 2019 Q2 | 11.45 Million USD | -3.27% |
| 2019 Q3 | 11.74 Million USD | 2.54% |
| 2019 Q4 | 13.09 Million USD | 11.47% |
| 2019 FY | - USD | 15.51% |
| 2018 Q4 | 11.52 Million USD | 11.77% |
| 2018 Q3 | 10.31 Million USD | 7.64% |
| 2018 FY | - USD | 7.02% |
| 2018 Q2 | 9.58 Million USD | -6.58% |
| 2018 Q1 | 10.25 Million USD | 3.82% |
| 2017 Q1 | 11.11 Million USD | 9.87% |
| 2017 FY | - USD | 8.89% |
| 2017 Q4 | 9.88 Million USD | 18.72% |
| 2017 Q3 | 8.32 Million USD | -13.6% |
| 2017 Q2 | 9.63 Million USD | -13.32% |
| 2016 Q3 | 8.43 Million USD | 3.29% |
| 2016 FY | - USD | 12.88% |
| 2016 Q2 | 8.16 Million USD | -9.88% |
| 2016 Q1 | 9.05 Million USD | -7.71% |
| 2016 Q4 | 10.11 Million USD | 19.95% |
| 2015 Q4 | 9.81 Million USD | 29.04% |
| 2015 Q2 | 7.4 Million USD | 7.96% |
| 2015 Q1 | 6.86 Million USD | -7.78% |
| 2015 FY | - USD | -1.59% |
| 2015 Q3 | 7.6 Million USD | 2.71% |
| 2014 Q4 | 7.43 Million USD | -8.52% |
| 2014 FY | - USD | 12.52% |
| 2014 Q3 | 8.13 Million USD | 11.86% |
| 2014 Q2 | 7.27 Million USD | -22.32% |
| 2014 Q1 | 9.35 Million USD | 34.14% |
| 2013 Q2 | 6.49 Million USD | -20.78% |
| 2013 Q1 | 8.2 Million USD | 18.98% |
| 2013 FY | - USD | 4.26% |
| 2013 Q4 | 6.97 Million USD | 0.45% |
| 2013 Q3 | 6.94 Million USD | 6.93% |
| 2012 Q2 | 6.43 Million USD | -12.2% |
| 2012 Q3 | 6.8 Million USD | 5.72% |
| 2012 FY | - USD | 15.26% |
| 2012 Q4 | 6.89 Million USD | 1.29% |
| 2012 Q1 | 7.33 Million USD | 16.53% |
| 2011 Q1 | 6.94 Million USD | 88.62% |
| 2011 Q2 | 5.06 Million USD | -27.01% |
| 2011 Q3 | 5.51 Million USD | 8.7% |
| 2011 Q4 | 6.29 Million USD | 14.16% |
| 2011 FY | - USD | 28.25% |
| 2010 FY | - USD | 5.92% |
| 2010 Q1 | 6.44 Million USD | 51.53% |
| 2010 Q2 | 3.71 Million USD | -42.31% |
| 2010 Q3 | 4.71 Million USD | 26.89% |
| 2010 Q4 | 3.68 Million USD | -21.97% |
| 2009 Q2 | 3.59 Million USD | -34.5% |
| 2009 FY | - USD | 19.12% |
| 2009 Q4 | 4.25 Million USD | 1.31% |
| 2009 Q3 | 4.19 Million USD | 16.87% |
| 2009 Q1 | 5.48 Million USD | 47.97% |
| 2008 Q1 | 3.97 Million USD | 60.73% |
| 2008 FY | - USD | 6.24% |
| 2008 Q2 | 3.24 Million USD | -18.34% |
| 2008 Q4 | 3.7 Million USD | -2.14% |
| 2008 Q3 | 3.78 Million USD | 16.7% |
| 2007 Q1 | 3.34 Million USD | 28.35% |
| 2007 FY | - USD | 13.32% |
| 2007 Q4 | 2.47 Million USD | -48.05% |
| 2007 Q3 | 4.76 Million USD | 45.24% |
| 2007 Q2 | 3.27 Million USD | -1.87% |
| 2006 Q2 | 2.65 Million USD | 11.19% |
| 2006 Q1 | 2.38 Million USD | -13.08% |
| 2006 Q3 | 4.58 Million USD | 72.88% |
| 2006 Q4 | 2.6 Million USD | -43.23% |
| 2006 FY | - USD | 20.0% |
| 2005 Q1 | 1.66 Million USD | -12.37% |
| 2005 Q2 | 2.01 Million USD | 20.61% |
| 2005 Q4 | 2.74 Million USD | -27.12% |
| 2005 FY | - USD | 8.09% |
| 2005 Q3 | 3.76 Million USD | 87.28% |
| 2004 Q4 | 1.9 Million USD | -42.23% |
| 2004 Q3 | 3.29 Million USD | 76.96% |
| 2004 Q2 | 1.86 Million USD | -21.46% |
| 2004 Q1 | 2.36 Million USD | 0.83% |
| 2004 FY | - USD | 6.85% |
| 2003 Q1 | 1.95 Million USD | -20.13% |
| 2003 FY | - USD | 8.1% |
| 2003 Q4 | 2.38 Million USD | -10.58% |
| 2003 Q3 | 2.63 Million USD | 39.1% |
| 2003 Q2 | 1.92 Million USD | -3.32% |
| 2002 Q4 | 2.45 Million USD | -10.37% |
| 2002 Q3 | 2.72 Million USD | 40.92% |
| 2002 Q1 | 980.48 Thousand USD | 14.34% |
| 2002 FY | - USD | 75.48% |
| 2002 Q2 | 1.93 Million USD | 85.0% |
| 2001 Q3 | 2.03 Million USD | 271.93% |
| 2001 FY | - USD | 0.37% |
| 2001 Q4 | 906.74 Thousand USD | -54.99% |
| 2001 Q1 | 1.14 Million USD | -10.87% |
| 2001 Q2 | 542.38 Thousand USD | -52.53% |
| 2000 Q3 | 1.36 Million USD | 24.89% |
| 2000 FY | - USD | 40.38% |
| 2000 Q4 | 1.28 Million USD | -6.06% |
| 2000 Q2 | 1.09 Million USD | 27.71% |
| 2000 Q1 | 845.81 Thousand USD | -38.36% |
| 1999 Q2 | 300 Thousand USD | -25.0% |
| 1999 Q1 | 400 Thousand USD | -42.86% |
| 1999 Q4 | 1.4 Million USD | 40.0% |
| 1999 Q3 | 1 Million USD | 233.33% |
| 1999 FY | - USD | -42.11% |
| 1998 Q4 | 1 Million USD | -12.5% |
| 1998 Q3 | 1 Million USD | -78.38% |
| 1998 Q2 | 3.7 Million USD | 825.0% |
| 1998 Q1 | 700 Thousand USD | 105.88% |
| 1998 FY | - USD | -10.94% |
| 1997 FY | - USD | 77.78% |
| 1997 Q1 | 3.4 Million USD | 0.0% |
| 1997 Q2 | 3.5 Million USD | 2.94% |
| 1997 Q4 | -6.8 Million USD | -244.68% |
| 1997 Q3 | 4.7 Million USD | 34.29% |
| 1996 FY | - USD | 17.72% |
| 1995 FY | - USD | 75.34% |
| 1994 FY | - USD | 210.87% |
| 1993 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Inovalon Holdings, Inc. | 186.56 Million USD | 75.351% |
| GE HealthCare Technologies Inc. | 3.56 Billion USD | 98.708% |
| Sharecare, Inc. | -67.25 Million USD | 168.375% |
| Progyny, Inc. | 64.46 Million USD | 28.667% |
| Aclarion, Inc. | -4.14 Million USD | 1210.638% |
| CareMax, Inc. | -590.46 Million USD | 107.788% |
| Simulations Plus, Inc. | 6.13 Million USD | -650.041% |
| CareCloud, Inc. | -31.29 Million USD | 246.964% |
| Forian Inc. | 2.75 Million USD | -1572.005% |
| Bullfrog AI Holdings, Inc. Warrants | -5.27 Million USD | 971.744% |
| Bullfrog AI Holdings, Inc. Common Stock | -5.27 Million USD | 971.744% |
| Minerva Surgical, Inc. | -20.07 Million USD | 329.089% |
| Omnicell, Inc. | 60.69 Million USD | 24.23% |
| Definitive Healthcare Corp. | -241.22 Million USD | 119.063% |
| Zhongchao Inc. | -4.9 Million USD | 1038.019% |
| Accolade, Inc. | -71.19 Million USD | 164.592% |
| Streamline Health Solutions, Inc. | -12.81 Million USD | 458.809% |
| Ontrak, Inc. | -14.41 Million USD | 418.986% |
| SOPHiA GENETICS SA | -70.7 Million USD | 165.042% |
| R1 RCM Inc. | 426.2 Million USD | 89.21% |
| Spok Holdings, Inc. | 26.29 Million USD | -74.868% |
| Privia Health Group, Inc. | 27.18 Million USD | -69.174% |
| EUDA Health Holdings Limited | -8.3 Million USD | 654.012% |
| HeartBeam, Inc. | 675 Thousand USD | -6712.593% |
| GeneDx Holdings Corp. | -136.46 Million USD | 133.699% |
| TruBridge, Inc. | -15.39 Million USD | 398.779% |
| Nutex Health, Inc. | -14.58 Million USD | 415.368% |
| Renalytix Plc | -28.52 Million USD | 261.232% |
| Sharecare, Inc. | -67.25 Million USD | 168.375% |
| Health Catalyst, Inc. | -66.46 Million USD | 169.19% |
| 10x Genomics, Inc. | -205.11 Million USD | 122.42% |
| GoodRx Holdings, Inc. | 108.82 Million USD | 57.744% |
| SCWorx Corp. | -3.97 Million USD | 1256.944% |
| Schrödinger, Inc. | -171.89 Million USD | 126.752% |
| HealthEquity, Inc. | 282.41 Million USD | 83.717% |
| HealthStream, Inc. | 59.58 Million USD | 22.827% |
| MSP Recovery, Inc. | -69.22 Million USD | 166.432% |
| Augmedix, Inc. | -17.68 Million USD | 360.081% |
| BrightSpring Health Services, Inc. Common Stock | 349.51 Million USD | 86.843% |
| Ontrak, Inc. | -14.41 Million USD | 418.986% |
| SHL Telemedicine Ltd. | 3.28 Million USD | -1300.481% |
| CareCloud, Inc. | -31.29 Million USD | 246.964% |
| Premier, Inc. | 286.08 Million USD | 83.926% |
| Certara, Inc. | 23.84 Million USD | -92.858% |
| GeneDx Holdings Corp. | -136.46 Million USD | 133.699% |
| OneMedNet Corporation | -11.97 Million USD | 484.145% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 349.51 Million USD | 86.843% |
| EUDA Health Holdings Limited | -8.3 Million USD | 654.012% |
| HeartBeam, Inc. | 675 Thousand USD | -6712.593% |
| CareCloud, Inc. | -31.29 Million USD | 246.964% |
| Mangoceuticals, Inc. | -9.18 Million USD | 600.515% |
| CareMax, Inc. | -590.46 Million USD | 107.788% |
| Healthcare Triangle, Inc. | -4.1 Million USD | 1220.492% |
| Aclarion, Inc. | -4.14 Million USD | 1210.638% |
| OptimizeRx Corporation | -21.3 Million USD | 315.807% |